Quarterly report pursuant to Section 13 or 15(d)

Long-Term Debt and Notes Payable (Details)

v3.7.0.1
Long-Term Debt and Notes Payable (Details)
6 Months Ended
Jul. 01, 2017
USD ($)
fiscal_quarter
Debt Instrument  
Duration of permitted leverage ratio following acquisition, number of fiscal quarters | fiscal_quarter 2
Leverage ratio 1.77
Interest coverage ratio 24.2
Amended and Restated Credit Agreement  
Debt Instrument  
Maturity date of loans Jan. 13, 2021
Ratio of funded debt to Adjusted EBITDA 3.5
Minimum interest coverage ratio 3.0
Amended and Restated Credit Agreement | Maximum  
Debt Instrument  
Ratio of funded debt to Adjusted EBITDA 4.0
Amended and Restated Credit Agreement | Line of Credit | Revolving Credit Facility  
Debt Instrument  
Maximum borrowing capacity $ 350,000,000
Line of credit facility increase amount 150,000,000
Credit facility outstanding 152,000,000
Revolving credit facility remaining $ 196,900,000
Amended and Restated Credit Agreement | Line of Credit | Revolving Credit Facility | Minimum  
Debt Instrument  
Basis points for commitment fee 0.175%
Amended and Restated Credit Agreement | Line of Credit | Revolving Credit Facility | Minimum | LIBOR  
Debt Instrument  
Basis points for variable interest rate 1.375%
Amended and Restated Credit Agreement | Line of Credit | Revolving Credit Facility | Maximum  
Debt Instrument  
Basis points for commitment fee 0.35%
Amended and Restated Credit Agreement | Line of Credit | Revolving Credit Facility | Maximum | LIBOR  
Debt Instrument  
Basis points for variable interest rate 2.25%
Amended and Restated Credit Agreement | Line of Credit | Letter of Credit  
Debt Instrument  
Credit facility allocated (up to) $ 20,000,000
Outstanding letters of credit $ 1,100,000